Learn more

HINZMANN BERND

Overview
  • Total Patents
    11
About

HINZMANN BERND has a total of 11 patent applications. Its first patent ever was published in 1995. It filed its patents most often in Germany, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets biotechnology, measurement and pharmaceuticals are PRIDE PROTEOMICS AS, INST OF MICROBIOLOGY AND EPIDEMIOLOGY THE ACAD OF MILITARY MEDICAL SCIENCES and MURACA PATRICK J.

Patent filings in countries

World map showing HINZMANN BERNDs patent filings in countries

Patent filings per year

Chart showing HINZMANN BERNDs patent filings per year from 1900 to 2020

Focus industries

Top inventors

# Name Total Patents
#1 Hinzmann Bernd 11
#2 Rosenthal Andre 8
#3 Pilarsky Christian 6
#4 Staub Eike 6
#5 Dahl Edgar 6
#6 Bruemmendorf Thomas 5
#7 Li Xinzhong 5
#8 Kinnemann Henrik 5
#9 Specht Thomas 5
#10 Hermann Klaus 5

Latest patents

Publication Filing date Title
WO2012131092A2 Method and kits for the prediction of response/nonresponse to the treatment with an anti-egfr antibody in patients with colorectal cancer of all uicc stages
WO2004076614A2 Human nucleic acid sequences obtained from prostatic carcinomas
DE10339820A1 Use of G-protein coupled receptor, GPR49, peptides, protein and nucleic acid, for diagnosis and prognosis of tumors, also in screening for therapeutic and diagnostic agents
DE10322134A1 New nucleic acids, and encoded proteins, from prostatic cancer tissue, useful for diagnosis, treatment and in screening for specific binding agents
DE10316701A1 New nucleic acid, and derived proteins, useful for diagnosis of bronchial cancer and in screening for therapeutic and diagnostic agents
DE10315834A1 Human nucleic acid sequences from pancreatic carcinomas
DE10309985A1 New nucleic acids, and encoded proteins, from prostatic cancer tissue, useful for diagnosis, treatment and in screening for specific binding agents
DE10309729A1 Human nucleic acid sequences from bladder cancer